GxPaaS
GxPaaS is a SAAS platform targeting the 50% efficiency loss that currently plagues pen and paper testing methods employed by 90% of Life Sciences manufacturers.
- Stage Prototype Ready
- Industry Biotechnology
- Location Raleigh, NC, USA
- Currency USD
- Founded April 2022
- Employees 1
- Incorporation Type C-corp
- Website gxpaas.io
Company Summary
Despite numerous advancements that have reduced the time to market for life-saving therapies, the testing of manufacturing systems remains an archaic pen and paper process for 90% of the industry. GxPaaS is a SAAS platform that delivers a fully electronic solution for this activity. This approach eliminates the estimated 50% waste due to clerical activities and human error, reducing both time and risk when bringing new medicines to market.
Team
Previous Investors
-
Michael GagneUnconfirmed
John RozemberskyUnconfirmed -
Anand SaravaneUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.